University of Minnesota
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Minnesota sits in the top decile of US sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count).
University of Minnesota: 966 sponsored US clinical trials, 180 recruiting.
University of Minnesota sponsors 966 registered US clinical trials on ClinicalTrials.gov, 180 of them currently recruiting, and 671 completed. 71 of these trials are in Phase 3-4 (later-stage) and 206 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 14 trials.
Top-decile sponsor footprint
University of Minnesota ranks in the top decile of sponsors by registered trial count (#33 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
671 of 731 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
966 total, page 16 of 20
Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms
NCT01522963
Evaluating the Effect of a Decision Aid on Shared Decision Making for Prostate Cancer Screening
NCT01484665
Stem Cell Therapy in Patients With Severe Heart Failure & Undergoing Left Ventricular Assist Device Placement
NCT00869024
Bariatric Surgery And Adipose Inflammation Dysfunction and Type 2 Diabetes Mellitus
NCT01882036
rTMS and Retraining in Focal Hand Dystonia
NCT01738581
Location of GLP-1 Release
NCT02036710
Using Motivational Interviewing To Reduce Parental Risk-Related Behaviors For Early Childhood Caries
NCT04286256
Vikings Fitness Playbook: A Family Based Lifestyle Modification Program for Overweight and Obese Youth
NCT01442415
For the Health of Our Children--Clinic Based Treatment of Childhood Obesity
NCT01625910
Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth
NCT01442753
Detection of Pathological Lymphocytes in Patients With Autoimmune Disease
NCT02813083
Detecting Dopaminergic Deficits in Individuals At-risk for Parkinsonism
NCT01358474
Intravenous N-acetylcysteine for the Treatment of Gaucher's Disease and Parkinson's Disease
NCT01427517
Pilot Study of Lisdexamfetamine for Treatment of Cocaine Dependence
NCT01490216
Treating Kidney Donors With Valganciclovir to Reduce Viral Transmission to Recipients
NCT01329185
Antihypertensive Treatment of Acute Cerebral Hemorrhage-II
NCT01176565
Gut Health Response to Dietary Fiber
NCT01321736
Early Study of N-Acetylcysteine to Treat Deliberate Self-Harm in Adolescents
NCT01111734
Choosing Healthy Options in College Environments and Settings
NCT01134783
A Study of Diazepam After Intranasal and Intravenous Administration to Healthy Volunteers
NCT01364558
A Chronic Care Model Based Quality Improvement (QI) Program to Improve the Care of Patients With Chronic Kidney Disease (CKD)
NCT01290614
Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia
NCT01408732
Offering Proactive Tobacco Treatment
NCT01123967
Laryngeal Mask Airway (LMA) for Surfactant Administration in Neonates
NCT01116921
Palatability of Experimental Cigarettes - Study 2
NCT01568905
P60 Program Project Grant-Outreach for Smoke-Free Homes
NCT01574560
Satiety Response of White and Brown Rice Compared to Glucose Control
NCT01508975
Multimodal Functional Neuroimaging in Epilepsy Patients
NCT02132507
Yoga for Managing Knee Osteoarthritis in Older Women: a Feasibility Study
NCT01832155
Neurobehavioral Phenotypes in MPS III
NCT01873911
Gene Therapy for Tay-Sachs Disease
NCT01869270
Preventing Obesity in the Worksite: A Multi-Message, Multi-"Step" Approach
NCT01585480
An Adaptive Treatment Strategy for Adolescent Depression
NCT01802437
Satiety Response of Four Dietary Fibers
NCT01233024
Markers of Endothelial Function and Exercise CapaciTy in Patients With Left Ventricular Assist Devices (EFECT LVAD)
NCT01233037
Development of a Biomarker for Dietary Furanocoumarins
NCT01142037
Exenatide in Extreme Pediatric Obesity
NCT01237197
Initial Stability of Posterior Maxillary Implants With Bicortical Fixation
NCT01237184
Prospective Radiologic Evaluation of Changes Following Fat Grafting
NCT01343030
Portion Size Effects on Body Weight:Free Living Setting
NCT01820403
Trial of L-DOPA as a Treatment to Improve Vision in Albinism
NCT01176435
Three-dimensional Assessment of Craniofacial Structures
NCT01210547
Positive Angle Kappa
NCT01644552
Sitagliptin Therapy to Improve Outcomes After Islet Autotransplant
NCT01186562
Local Field Potentials Recorded From Deep Brain Stimulating (DBS) Electrodes
NCT01427530
Genetic Evaluation of NF1 and Scoliosis Patients
NCT01776125
Postnatal Choline Supplementation in Children With Prenatal Alcohol Exposure
NCT01149538
Effect of Temperature on Pain and Brown Adipose Activity in Fibromyalgia
NCT01322425
Healthy Home Offerings Via the Mealtime Environment (HOME) Plus
NCT01538615
Effect of Food Form on Satiety and Gastric Emptying
NCT01102907
What is open in the University of Minnesota pipeline
180 recruiting of 966 indexed (19% open); 671 completed (69%).
Phase mix: 71 late (III/IV) vs 206 early (I/II) (early-phase heavy).
Top condition: Obesity (14 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Minnesota: open-pipeline peers nationwide
Peers matched on 966 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
University of Minnesota sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 966 trials (± recruiting share)
- Columbia University · 958 trials · 18% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
Sponsors near 19% open enrollment (± trial volume)
- University of Alabama at Birmingham · 19% recruiting · 1,160 trials
- Mclean Hospital · 19% recruiting · 140 trials
- Children's Hospital Medical Center, Cincinnati · 19% recruiting · 571 trials
- Arkansas Children's Hospital Research Institute · 19% recruiting · 97 trials
Related
What to do with this University of Minnesota page
966 registered trials is a research-attention snapshot, not an endorsement of University of Minnesota or any single study.
- 180 of University of Minnesota's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition University of Minnesota studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Minnesota pipeline card: 966 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.